Violence, Physical — Entrepreneurship and Beekeeping in Tanzania
Citation(s)
Banks N Youth poverty, employment and livelihoods: Social and economic implications of living with insecurity in Arusha, Tanzania. Environment and Urbanization. 2016; 28(2), 437-454.
Dempsey D, Jennings J Gender and entrepreneurial self-efficacy: learning perspective. International Journal of Gender and Entrepreneurship. 2014; 6 (1), 28-49
NBS (National Bureau of Statistics) Basic Demographic and Socio-economic Profile of Dar es Salaam Region. 2016. Dar es Salaam, Tanzania: Ministry of Finance.
Outwater AH, Campbell JC, Mgaya E Implementation of WHO/CDC Guidelines for Intentional Injury Death Surveillance: A Mixed-Methods Approach in Dar es Salaam, Tanzania. Homicide Stud. 2011 Aug;15(3):253-267.
World Bank Group From Regulators to Enablers: the Role of City Governments in Economic Development of Greater Kampala. Washington, D.C.: The World Bank. 2017. Accessed at https://openknowledge.worldbank.org/bitstream/handle/10986/28459/119806-REVISED-PUBLIC-ADD-AUTHORS-P158599-GreaterKampalaFinalOutput.pdf
Yamanis TJ, Maman S, Mbwambo JK, Earp JA, Kajula LJ Social venues that protect against and promote HIV risk for young men in Dar es Salaam, Tanzania. Soc Sci Med. 2010 Nov;71(9):1601-9. doi: 10.1016/j.socscimed.2010.07.039. Epub 2010 Sep 16.
Entrepreneurship and Beekeeping for Young Men at Risk for Violence in Dar es Salaam Tanzania: A Pilot Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
